Selective Inhibition of JAK1 Primes STAT5-Driven Human Leukemia Cells for ATRA-Induced Differentiation - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/34324169/
doi: 10.1007/s11523-021-00830-5. Online ahead of print. 1 Cancer Biology Program, Vanderbilt University School of Medicine, Nashville, TN, USA. 2 Department of Medicine, Vanderbilt University School of Medicine, Nashville, TN, USA....
Deletion of AMPK minimizes graft-versus-host disease through an early impact on effector donor T cells - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/34291733/
Allogeneic hematopoietic stem cell transplantation is a viable treatment for multiple hematologic diseases, but its application is often limited by graft-versus-host disease (GVHD), where donor T cells attack host tissues...
HLA-haploidentical vs matched unrelated donor transplants with posttransplant cyclophosphamide-based prophylaxis - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/34292325/
1 Department of Hematology/Oncology, Dana-Farber Cancer Institute, Boston, MA. 2 Center for International Blood and Marrow Transplant Research (CIBMTR), Department of Medicine, Medical College of Wisconsin, Milwaukee, WI. 3 Division...
Graft Versus Host Disease After Intestinal Transplantation: A Single-center Experience - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/34291153/
doi: 10.1097/TXD.0000000000001187. 1 MedStar Georgetown Transplant Institute, MedStar Georgetown University Hospital, Washington, DC. 2 Georgetown University School of Medicine, Washington, DC. 3 Histocompatibility Laboratory, MedStar Georgetown University Hospital, Washington, DC....
Efficiency and Toxicity of Ruxolitinib as a Salvage Treatment for Steroid-Refractory Chronic Graft-Versus-Host Disease - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/34276662/
doi: 10.3389/fimmu.2021.673636. 1 National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, Key Laboratory of Thrombosis and Hemostasis of Ministry of Health, The First Affiliated Hospital of Soochow...